Validation of a Digital Headache Calendar at a Tertiary Referral Center
- PMID: 38201330
- PMCID: PMC10795797
- DOI: 10.3390/diagnostics14010021
Validation of a Digital Headache Calendar at a Tertiary Referral Center
Abstract
Background: Headache calendars are essential tools in monitoring changes in headache frequency and type. They are used in clinical practice for long-term monitoring, but their validation remains limited. The aim of this study was to validate the use of a digital calendar in monitoring single migraine and tension-type headache attacks.
Methods: From July 2022 to February 2023, patients diagnosed with migraine and tension-type headache were enrolled. The validation of the digital calendar involved the comparison of self-reported single headache attacks in the digital calendar with the diagnostic headache diary based on the ICHD-3 criteria for migraine and tension-type headache. Sensitivity and specificity were calculated to assess reliability, and the level of agreement was calculated using kappa statistics.
Results: This study included 30 patients (87% women) diagnosed with migraine and tension-type headache. The level of agreement in the classification of a single migraine attack revealed a sensitivity of 82% and a specificity of 78%, representing a substantial level of agreement (κ = 0.60). The classification of a single tension-type headache attack revealed a sensitivity of 84% and a specificity of 72%, with a moderate level of agreement (κ = 0.54).
Conclusions: The digital calendar proves effective in monitoring single headache attacks in patients with migraine and tension-type headache. In clinical practice, we recommend using the digital calendar as a monitoring tool for headache patients, as they can accurately identify true migraine and tension-type headache days.
Keywords: digital calendar; migraine; tension-type headache; validation study.
Conflict of interest statement
L.N.C. has given lectures for Novartis, Allergan and TEVA, and has provided consulting advice to Lundbeck. H.S. has received personal fees from Novartis, Lilly, Allergan/AbbVie, Teva and Lundbeck and research support from Novartis. The additional authors had no conflicts of interest.
Similar articles
-
Validation of an algorithm for automated classification of migraine and tension-type headache attacks in an electronic headache diary.J Headache Pain. 2020 Jun 12;21(1):75. doi: 10.1186/s10194-020-01139-w. J Headache Pain. 2020. PMID: 32532222 Free PMC article.
-
A prospective study on osmophobia in migraine versus tension-type headache in a large series of attacks.Cephalalgia. 2020 Apr;40(4):337-346. doi: 10.1177/0333102419877661. Epub 2019 Sep 19. Cephalalgia. 2020. PMID: 31537108
-
Development and Validation of a Japanese-Language Questionnaire to Screen for Tension-Type Headaches and Migraines.Cureus. 2023 Sep 4;15(9):e44633. doi: 10.7759/cureus.44633. eCollection 2023 Sep. Cureus. 2023. PMID: 37799235 Free PMC article.
-
Pericranial Total Tenderness Score in Patients with Tension-type Headache and Migraine. A Systematic Review and Meta-analysis.Pain Physician. 2021 Dec;24(8):E1177-E1189. Pain Physician. 2021. PMID: 34793636
-
Diagnostic lessons from the spectrum study.Neurology. 2002 May 14;58(9 Suppl 6):S27-31. doi: 10.1212/wnl.58.9_suppl_6.s27. Neurology. 2002. PMID: 12011271 Review.
Cited by
-
Hallmarks of primary headache: part 2- Tension-type headache.J Headache Pain. 2025 Jul 17;26(1):164. doi: 10.1186/s10194-025-02098-w. J Headache Pain. 2025. PMID: 40676501 Free PMC article. Review.
References
-
- Tassorelli C., Sances G., Allena M., Ghiotto N., Bendtsen L., Olesen J., Nappi G., Jensen R. The usefulness and applicability of a basic headache diary before first consultation: Results of a pilot study conducted in two centres. Cephalalgia. 2018;28:1023–1030. doi: 10.1111/j.1468-2982.2008.01639.x. - DOI - PubMed
-
- Nielsen K.D., Rasmussen C., Russell M.B. The diagnostic headache diary--a headache expert system. Stud Health Technol. Inform. 2000;78:149–160. - PubMed
LinkOut - more resources
Full Text Sources